Back to Research
Strong EvidenceAnimal Study

Eight Hyped Compounds Failed to Extend Lifespan in a Major Mouse Study

GeroScienceMarch 16, 2026Sample Size: UM-HET3 mice across three sites (exact N not specified)

Summary

The NIA's Interventions Testing Program tested eight compounds across three lab sites in genetically diverse mice. None extended lifespan. That includes astaxanthin, alpha-ketoglutarate, pioglitazone, atorvastatin-telmisartan, and others with prior promising results. Some compounds previously shown to work at different doses or start ages didn't replicate under new conditions. Two drugs actually shortened lifespan in female mice.

Practical Takeaway

This study suggests that dose and timing matter enormously, and early lifespan results in mice often don't hold up.

Disclaimer: Research summaries are provided for informational purposes only and do not constitute medical advice. Always consult a qualified healthcare professional before making changes to your health routine.